• Something wrong with this record ?

Tumor-associated carbonic anhydrases and their clinical significance

Pastorekova S., Parkkila S., Zavada J.

. 2006 ; 42 () : 167-216.

Language English Country United States

Document type Review

Carbonic anhydrases (CAs) are physiologically important enzymes that catalyze a reversible conversion of carbon dioxide to bicarbonate and participate in ion transport and pH control. Two human isoenzymes, CA IX and CA XII, are overexpressed in cancer and contribute to tumor physiology. Particularly CA IX is confined to only few normal tissues but is ectopically induced in many tumor types mainly due to its strong transcriptional activation by hypoxia accomplished via HIF-1 transcription factor. Therefore, CA IX can serve as a surrogate marker of hypoxia and a prognostic indicator. CA IX appears implicated in cell adhesion and in balance of pH disturbances caused by tumor metabolism. Both tumor-related expression pattern and functional involvement in tumor progression make it a suitable target for anticancer treatment. Here we summarize a current knowledge on CA IX and CA XII, and discuss possibilities of their exploitation for cancer detection, diagnostics, and therapy.

000      
00000naa 2200000 a 4500
001      
bmc07524106
003      
CZ-PrNML
005      
20150814104751.0
008      
090529s2006 xxu e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Pastoreková, Silvia, $d 1961- $7 xx0086555
245    10
$a Tumor-associated carbonic anhydrases and their clinical significance / $c Pastorekova S., Parkkila S., Zavada J.
314    __
$a Centre of Molecular Medicine, Institute of Virology, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovak Republic. virusipa@savba.sk
520    9_
$a Carbonic anhydrases (CAs) are physiologically important enzymes that catalyze a reversible conversion of carbon dioxide to bicarbonate and participate in ion transport and pH control. Two human isoenzymes, CA IX and CA XII, are overexpressed in cancer and contribute to tumor physiology. Particularly CA IX is confined to only few normal tissues but is ectopically induced in many tumor types mainly due to its strong transcriptional activation by hypoxia accomplished via HIF-1 transcription factor. Therefore, CA IX can serve as a surrogate marker of hypoxia and a prognostic indicator. CA IX appears implicated in cell adhesion and in balance of pH disturbances caused by tumor metabolism. Both tumor-related expression pattern and functional involvement in tumor progression make it a suitable target for anticancer treatment. Here we summarize a current knowledge on CA IX and CA XII, and discuss possibilities of their exploitation for cancer detection, diagnostics, and therapy.
650    _2
$a karboanhydrasy $x metabolismus $7 D002256
650    _2
$a lidé $7 D006801
650    _2
$a nádory $x enzymologie $7 D009369
650    _2
$a financování organizované $7 D005381
655    _2
$a přehledy $7 D016454
700    1_
$a Parkkila, Seppo
700    1_
$a Závada, Jan, $d 1933- $7 nlk19990074094
773    0_
$w MED00182955 $t Advances in clinical chemistry $g Roč. 42(2006), s. 167-216 $x 0065-2423
910    __
$a ABA008 $b x $y 9 $z 0
990    __
$a 20090519102933 $b ABA008
991    __
$a 20150814104855 $b ABA008
999    __
$a ok $b bmc $g 659653 $s 515064
BAS    __
$a 3
BMC    __
$a 2006 $b 42 $d 167-216 $m Advances in clinical chemistry $x MED00182955 $i 0065-2423
LZP    __
$a 2009-B2/dkme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...